A study of the interaction of omeprazole and warfarin in anticoagulated patients
about
Pharmacokinetic drug interaction profiles of proton pump inhibitors: an updateThe nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillationSelection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.Pharmacokinetic drug interaction profiles of proton pump inhibitors.Probable interaction between warfarin and marijuana smoking.Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of racemic warfarin in healthy subjects.Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isozyme diversity determines the differences in their pharmacokinetics.Drug interactions in oncology: how common are they?Drug-drug interaction profiles of proton pump inhibitors.Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin.Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro.Gastroesophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment.Monitoring the distribution of warfarin in blood plasmaCo-prescription of H2 receptor blockers and proton pump inhibitors with warfarin in general practice.Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test.A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole.Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4.Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.General medicine and surgery for dental practitioners. Part 3: gastrointestinal system.Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.Safety issues relating to long-term treatment with histamine H2-receptor antagonists
P2860
Q27022254-CF9AA9DB-06A2-43B2-BB5F-687EA4A6DB45Q28194361-95D7423A-E6AB-4369-B32E-9EB43EDA3F22Q34078487-A180C477-8AC1-493E-BF70-25294C584C35Q34570478-6DAA3E5F-C670-4CA3-A704-6B2B8E290A12Q34987234-68CE2353-BE31-45BC-AE82-CDB693B1462DQ35826894-C5C6DF6F-3F4C-447E-BD43-8A142F6CBFB6Q36330247-1460CDBE-97E1-40DB-A7C7-0CA23D192B94Q37588305-1A0B5064-F39D-46FB-8CC3-EB56D9DBA0AAQ37770556-A2901202-B360-4B4B-9AFE-556CD5D0E65DQ38024092-2EC9C130-28B7-4E48-A0F8-117E38B71059Q38514724-FA8C0CBC-41C9-4227-9C13-CA786FC08CE7Q39402812-C76755EA-634E-4E41-96B8-7B62830848E6Q39736279-982A0230-90F9-4DBD-9C92-C1D37D54181BQ43065846-6D14C2D5-BFAF-43DB-B532-89D783DD6E44Q43201988-D0E45B4B-AF80-432F-9BC7-2523DB9E995DQ44402560-05E6F56F-1932-4EE3-9956-A15A39409415Q45201783-A59F9FA0-88B0-4445-8E1F-C72294F4C5C6Q46738440-112ECB00-6D84-4DAB-B0A8-496CDA21E828Q48610637-83F50CDA-CD2F-4624-841E-A17DB4E7259DQ50925811-AF63A752-1E3E-4427-B63C-D9CDD4E51A56Q51294071-887AAA67-B370-4E1A-AE1F-1AC808F994FAQ53156912-A6B69590-1F45-450F-AD45-8A19E38BE229Q56453392-64DB2C5F-851C-425F-8D5E-1BFA8738237D
P2860
A study of the interaction of omeprazole and warfarin in anticoagulated patients
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@ast
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@en
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@nl
type
label
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@ast
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@en
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@nl
prefLabel
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@ast
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@en
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@nl
P2093
P2860
P1476
A study of the interaction of omeprazole and warfarin in anticoagulated patients
@en
P2093
Andersson T
Idström JP
Lagerström PO
Nordgren A
Svedberg LE
P2860
P304
P356
10.1111/J.1365-2125.1992.TB05656.X
P407
P577
1992-12-01T00:00:00Z